MLLStart! advised Clinical Research Ventures. Walder Wyss advises BioVersys. BioVersys AG, a privately-held clinical-stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies for...
BioVersys’ CHF 24.2 Million Series C Financing Round
Adiposs’ CHF 1.8 Million Pre-Series A Round
MLL advised Clinical Research Ventures (CR Ventures). Adiposs, the developer of a unique diagnostic product for the non-invasive early detection of body wasting cachexia, announced a...